| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| October 30, 2025 | ±2.0% | +7.7% | under-priced |
| July 31, 2025 | ±1.4% | +4.6% | under-priced |
| May 1, 2025 | ±2.3% | -1.4% | over-priced |
| October 31, 2024 | ±1.3% | +8.5% | under-priced |
| August 1, 2024 | ±2.2% | -8.3% | under-priced |
| May 2, 2024 | ±1.4% | -6.1% | under-priced |
| October 31, 2023 | ±1.4% | +0.5% | over-priced |
| August 1, 2023 | ±1.1% | +0.5% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q4 FY2025 | $1.73 | $2.0B | $399M |
| Q3 FY2025 | $1.60 | $1.9B | $371M |
| Q2 FY2025 | $1.55 | $1.8B | $358M |
| Q1 FY2025 | $1.52 | $1.7B | $352M |
Ametek, Inc. (AME) reports imminently, with the next report estimated for April 28, 2026. Across the last 8 reports, options priced an average ±1.6% earnings move while the stock actually moved 4.7% on average — the market has been roughly fair on AME's earnings risk. Fundamentals into the print: EPS up 3.6% year-over-year, revenue up 13.4%. QuantLogix's live 5-factor engine currently reads AME as a buy at 58/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →